Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

May 06, 2014

Cancer Omics—How Much Information is Enough?

Knowledge is power, but is that knowledge always worth the cost?

Cancer Omics—How Much Information is Enough?

The 21-gene expression Oncotype DX assay was developed to estimate the benefit of adjuvant chemotherapy for hormone receptor–positive breast cancer. [©Tyler Olson/Fotolia]

All genomic evidence points to increasing complexity in analyzing cancers for molecular characterization to indicate an appropriate treatment course and determine prognosis But while we wait for interpretable results to emerge from mountains of data, can a few gene signatures, other types of omics tests, and even animal-based testing, provide ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.

Related content